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firm scientific basis. Most epileptic patients can be con-
trolled without side-effects or signs and symptoms of
toxicity. However, the clinician may sometimes find it
necessary to deviate from accepted principles to gain
control in the exceptional case.
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Ascaris lumbricoides and Allergic Asthma
ANew Per-spective
J. R. JOUBERT, H. C. DE KLERK, C. MALAN
)
SUMMARY
Infestation of humans with the parasite Ascaris Jumbfl·
coides may induce high total serum IgE levels, but the
influence of this immunogenic response on allergic asthma
has not been defined. In this study, the specific anti-
parasitic IgE-mediated response as determined by skin-
prick testing was related to the incidence of allergic
asthma in Ascaris-infested patients. A limited number
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- 17% of the non-allergic controls and 51% of the
allergic asthmatics - had a clinically detectable immu-
nogenic response to the parasite. The predicted incidence
of asthma was significantly higher than the observed
incidence in the subjects in whom the Ascaris skin test
was positive. This was not found in subjects in whom the
Ascaris skin test was negative. Inhalation of Ascaris
antigen induced asthmatic reactions in 7 of 8 patients who
were Ascaris-positive on skin testing, but not in the nega-
tive controls. The groups of patients who respond im-
munogenically to parasite infestation need to be defined,
as they may be predisposed to allergic diseases such as
asthma.
S. Afr. med. l., 56, 599 (1979).
The influence of Ascaris /umbricoides on allergic asthma
remains controversial. The presence of A scaris ova in
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the stools of 90o~ of the asthmatics studied by Tullis'
led him to conclude that there was a marked correlation
between the manifestations of bronchial asthma and the
presence of intestinal parasites. However, Van Dellen
er al.' were unable to reproduce these results.
Extremely high serum IgE levels have been recorded
in Ascaris-infested patients." A direct relationship between
these levels and the incidence of asthma has, however,
not been established. The answer to the question whether
all Ascaris-infested patients have parasite-specific IgE re-
sponses may resolve the Ascaris-asthma controversy.
Burger' found in 1968 that Ascaris and Trichuris
trichiura infestation has a 95,7% prevalence among
Coloured schoolchildren in the Western Cape. The warm
climate, high humidity and sandy soil of this region
produce ideal conditions for development of the ova.
Allergic asthma and hay fever are also extremely common
diseases in the local population.
In this study, a clinical measurement of the Ascaris
immunogenic response was related to parasite infestation
in allergic asthmatics and in non-allergic patients. Skin-
prick testing and bronchial provocation were used to
assess the immunogenic reactivity of patients to this
antigen. Results of these in vivo determinations of parasite
hypersensitivity were employed in an attempt to determine
whether this factor is associated with allergic asthma.
PATIENTS AND METHODS
Coloured patients from the Western Cape, between the
ages of 12 and 44 years, who attended the allergy clinic
of the Tygerberg Hospital with asthma and in some
cases with concomitant hay fever, were studied. This
age group was chosen so as to study the maximum
number of allergic asthmatics and the minimum with
chronic obstructive pulmonar;y disease. Age-matched
patients with no allergy symptoms and from the same
region, who had been admitted to the medical wards
for other reasons, were used as controls. A full history
of allergy was taken from every patient and special note
was made of the last date on which worms had been
passed. Patients were clinically examined and stools were
collected from co-operative patients and examined for
the presence of parasites. Skin-prick tests were performed,
with antigen extracts of 15 common airborne allergens
obtained from the Bencard Company, in 85 clinically
non-allergic subjects and in IQ9 allergic asthmatics. Tests
were also done with a 6% Ascaris extract, obtained from
the same company, in the two groups. Skin reactions of
3 mm diameter and larger were interpreted as positive.
The size of skin indurations was graded by two trained
staff members, according to a routine procedure. Ascaris-
positive and Ascaris-negative subgroups were defined by
means of the skin-prick reaction.
Bronchial Provocation with Ascaris lumbricoides
Antigen
All patients who participated in this part of the study
were younger than 35 years. Eight Ascaris-positive patients,
7 of whom were allergic asthmatics, were contrasted with
6 Ascaris-negative asthmatics, who served as controls.
Five of the 8 positive and 3 of the 6 negative patients
had ova in their stools at the time of the study, or were
aware of having passed worms a few weeks before, or
immediately after, bronchial provocation. The bronchial
response after provocation was determined by the method
described by Vermaak et al.' and Bunn et al." Patients:
recorded maximal expiratory flow volume curves on a"
Coleman dry spirometer. Flow and volume signals were:
relayed to an oscilloscope from which the flow volume
curve was photographed. The area below the flow volume
curve was planimetered and expressed as a percentage of
the control pre-inhalation value. These determinations
were done at IS-minute intervals for the first H· hours
after antigen inhalation and then hourly for another 6
hours, the last determination being at 24 hours. Asthmatics
on treatment took no medication for 12 hours before
bronchial provocation.
As a control prior to provocation with Ascaris antigen,
patients inhaled saline for 5 minutes, and the lung re-
sponse was determined at similar time intervals over an
8-hour period. The mean change was determined for
each individual the day after saline had been inhaled.
One standard deviation of this value was obtained and
expressed as a percentage of the mean, and a value
termed 'significant percentage change' was calculated in
this way for each individual. Reactions were defined as
an immediate response or a delayed response when the
change in the area below the flow volume curve was greater
than the significant percentage change at two points -or
more during the first 2 hours after inhalation (immediate
response) and at two points or more 4 hours after in-
halation (delayed response).
A 0,0006% Ascaris solution was used for an initial
I-minute period and two subsequent 2-minute periods of
bronchial provocation, and if this evoked no bronchial
response the antigen concentration was increased IQ-fold.
The concentration was increased if necessary until a 5-
minute period of provocation with a 0,06'% antigen
solution had been completed; 6 controls, subjects who
were Ascaris-negative on skin testing, also inhaled a 0,06%
solution for 5 minutes.
Bronchial Provocation with Non-Ascaris Antigen
The asthmatic response to non-Ascaris antigen was
tested by provocation in 3 of the 6 asthmatics who were
Ascaris-negative on skin testing and in I of the 8 asth-
matics who were positive. Antigen extracts employed in
the negative controls included feathers, grass pollen and
house-dust mite (Bencard Compaqy), while bronchial pro-
vocation was conducted with a house dust extract in the
positive subject.
RESULTS
Correlation between Stool and Ascaris Skin Test
Results
Skin test and stool results for allergic and non-allergic
patients were as follows, taking into account the .fact that
cross-reactivity exists between Ascaris antigen and TgE
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Predicted and Observed Incidences of Asthma
Fig. 1. Predicted and observed incidences of allergic
asthma in patients exposed to Ascaris lumbricoides.
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The relatively low incidence of allergic asthma among
rural Blacks living in areas where parasitic infestation
is endemic induced the hypothesis that parasite-specific
IgE saturates binding sites on mast cells, thereby pre-
DISCUSSION
Bronchial Provocation with Non-Ascaris Antigen
Immediate and delayed asthmatic responses to com-
mon inhaled allergens were recorded in all the 3 patients
who were Ascaris-negative on skin testing and in the I
patient who was positive (Fig. 3).
Fig. 2. Bronchial provocation with Ascaris antigen in
an asthmatic in whom the Ascaris skin test was positive.
Results of bronchial provocation in 8 subjects who
were positive on skin testing and 6 who were negative
were as follows: asthmatic responses were recorded in
7 of the 8 positive patients. The maximum antigen con-
centration employed to induce a bronchial response was
O,06°{, for 4 minutes. Immediate and delayed responses
were recorded in 3, a delayed response alone in I and
early responses alone in 3 patients. No asthmatic response
was recorded in I of the Ascaris-positive and in the 6
Ascaris-negative asthmatics.
tJ.%Av/v
t
The asthmatic response after inhalation of Ascaris anti-
gen in a patient who was Ascaris-positive on skin testing
is shown in Fig. 2. An immediate asthmatic response,
indicated by a decrease in the area below the flow volume
curve (vertical axis), was recorded within 15 minutes of
antigen inhalation. This was followed by a delayed re-
s;JQnse which reached maximum intensity 6t hours after
the onset of the asthmatic reaction.
both skin and stool testing. This was significantly higher
than the predicted incidence of asthma for the whole
group (P<O,Ol). The observed incidence of asthma in all
Ascaris-positive patients was also significantly higher than
the incidence in the patients with negative skin test re-
sponses (P<O,OOl).
Bronchial Provocation in Ascaris-Positive and
-Negative Asthmatics
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prociuced against T. trichiura. Patients who had Trichuris
ova ·in their stools along with Ascaris ova, or Trichuris
only, were thus included as positive on stool testing.
Fifty-one of 123 allergic asthmatics (41,5%) were
positive on skin testing and 57 (46,3%) had positive stools.
In the non-allergic group, 13 of 71 patients (18,3 %) were
positive on skin testing and 24 (33,8%) had positive stools.
Results of a correlation between stool and skin test
results for non-allergic patients were as follows: in the
grollP with negative stools, 9 of 47 patients (19°(,) had
skin reactions and 20 of 24 (83%) were negative. In the
gr0l1p with negative stools, 9 of 47 patients (19%) had
positive skin tests and 38 (81 °o) were negative on both
stool and skin testing.
10 allergic asthmatics, 29 of 57 (51 %) patients were
positive on both stool and skin testing, while 28 of 57
(49%) had positive stools but were negative on skin
testing. In the allergic asthmatic group with negative stools,
22 of 66 (33'%) were positive on skin testing and 44 of
66 (67%) were negative on both stool and skin testing.
A statistical correlation was found between stool and skin
test results in allergic asthmatics (P<0,05), but not in the
non-allergic group.
The predicted and observed incidences of asthma were
calculated for a group of 194 control non-allergic and
allergic asthmatic patients (Fig. I).
The predicted incidence of asthma for the whole group
was 64%. The patients who were Ascaris-negative on
stool and skin testing had an observed incidence of asth-
ma of 54%. An incidence of 58''/0 was recorded in the
grollP with positive stools but negative skin test results.
In a group with negative stools but positive skin test
reSUlts the incidence was 71 %. An observed incidence of
81)% was recorded in the group who were positive on
11
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Fig. 3. Asthmatic response to house dust challenge in a
patient with a positive bronchial response to Ascaris.
venting IgE specific for common inhaled allergens from
making contact with these cells in the respiratory tract,'
This interesting concept led to a suggestion in a leading
article in The Lancei' that allergic asthmatics should
deliberately be exposed to parasites whjch enhance anti-
parasite IgE synthesis.
The presence of functional or mast cell-bound IgE has
not previously been related to allergic asthma. The pre-
valence of asthma in subjects who have IgE-mediated,
anti-Ascaris skin responses suggests that their mast cells
participate actively in the asthmatic response, despite the
presence of Ascaris-specific IgE (Fig. I). The close corre-
lation found in this study between results of Ascaris skin
tests and bronchial provocation in 7 of 8 positive and
6 negative subjects has also been reported for common
inhaled allergens.'
Our data demonstrate the presence of Ascaris-specific
IgE on the bronchial mast cells of subjects who were
Ascaris-positive on skin testing. Clinically, the asthma
occurring in positive and negative subjects did not differ
in intensity, and the presence of parasite-specific IgE
on bronchial mast cells did not prevent acute asthmatic
episodes in the Ascaris-positive group. A clear biphasic
asthmatic reaction followed inhalation of a house dust
antigen extract in I subject who was positive to Ascaris
and to house dust antigens on skin testing (Fig. 3). These
data provide evidence of an Ascaris-specific immunogenic
response in the bronchi of patients who suffer from acute
asthma, and contradict the hypothesis of a protective
role for the parasite-specific JgE.
Only 17% of the clinically non-allergic and 51 % of
the allergic, parasite-infested subjects had positive, Ascaris-
specific immunogenic responses. The absence of a clinically
demonstrable immunogenic response to Ascaris antigen
in 49% of the allergic and parasite-infested asthmatics
needs to be considered when studying the relationship
between parasite infestation and asthma. Our data suggest
that a direct relationship between parasite infestation and
allergic asthma exists only in individuals in whom clinical
or laboratory evidence of a parasite-specific immuno-'
genic response can be demonstrated. The similarity of'
the preructed and observed incidences of asthma in para-
site-infested subjects who were Ascaris-negative on skin:
testing supports this concept (Fig. 1).
TO correlation was found in this study between an
anti-Ascaris immunogenic response and presence of para-
site ova in the stools of clinically non-allergic controls.
The absence of an immunogenic response in 83°~ of the
non-allergic patients with Ascaris-positive stools may relate
to a genetic inability of this group to produce anti-Ascaris
IgE. The positive skin tests in 19% of the non-allergic
and 33°0 of the allergic patients with negative stools may
be due to the fact that they had previously employed an
IgE-mediated immunogenic response to rid their gastro-
intestinal tracts of parasites, leaving them with anti-
parasite IgE on their mast cells, while the non-responders,
who were negative on skin testing, retained their parasites
in the gut. Animal experiments have provided evidence
in support of such an immunogenic mechanism for en-
hanced clearance of parasites.' °·u Similar evidence exists
in humans." The reason for the absence of an immuno-
genic response in 49% of the allergic asthmatics who were
parasite-infested is not entirely clear. The importance of
considering both the anti-parasite immunogenic response
and stool findings when studying the relationship between
Ascaris and asthma is clearly shown by these data. Identi-
fication of asthmatic patients with positive immunogenic
responses to Ascaris, especially those who also suffer
active infestation, is essential in areas of endemic in-
festation and may be of great therapeutic importance in
controlling asthmatic symptoms.
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